Targeting Pain-Suppressed Behaviors in Preclinical Assays of Pain and Analgesia: Effects of Morphine on Acetic Acid-Suppressed Feeding in C57BL/6J Mice

Journal of Pain

Volumn 7, Issue 6, 2006, Pages 408-416

  Stevenson, Glenn W ^a,b   Bilsky, Edward J ^b   Negus, S Stevens ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF NEW ENGLAND   (United States)

Author keywords

acetic acid; mice; morphine; Pain model; pain elicited behavior; pain suppressed behavior

Indexed keywords

ACETIC ACID; ANALGESIC AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; ENSURE; HALOPERIDOL; MORPHINE SULFATE; MU OPIATE RECEPTOR AGONIST; NALTREXONE; NEUROLEPTIC AGENT; WATER;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG SCREENING; DRUG TARGETING; FEEDING BEHAVIOR; FLUID INTAKE; LABORATORY TEST; MALE; MOTOR DYSFUNCTION; MOUSE; MOUSE STRAIN; NONHUMAN; PAIN; PAIN ASSESSMENT; PSYCHOPHARMACOLOGY; WRITHING TEST;

ACETIC ACID; ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DOPAMINE ANTAGONISTS; DRUG EVALUATION, PRECLINICAL; DRUG INTERACTIONS; FEEDING BEHAVIOR; HALOPERIDOL; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED C57BL; MORPHINE; NARCOTIC ANTAGONISTS; PAIN; PAIN MEASUREMENT; PREDICTIVE VALUE OF TESTS; RECEPTORS, OPIOID, MU; TIME FACTORS;

EID: 33646935403     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2006.01.447     Document Type: Article

References (37)

1. Blackburn-Munro G. Pain-like behaviours in animals-how human are they?. Trends Pharmacol Sci 25 6 (2004) 299-305
2. Carrasquillo Y., and Gereau R. Rodent models clarify the role of cells expressing the substance P receptor in pain. Drug Discovery Today 1 2 (2004) 107-113
3. Cedan C.M., Pujalte J.M., Portillo-Salido E., and Baeyens J.M. Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice. Psychopharmacology 182 (2005) 485-493
4. Collier H.O., Dinneen L.C., Johnson C.A., and Schneider C. The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol 32 2 (1968) 295-310
5. Dykstra L.A., and Woods J.H. A tail withdrawal procedure for assessing analgesic activity in rhesus monkeys. J Pharmacol Methods 15 3 (1986) 263-269
6. Erichsen H.K., Hao J.-X., Xu X.-J., and Blackburn-Munro G. Comparative actions of the opioid analgesics morphine, methadone and codeine in rat models of peripheral and central neuropathic pain. Pain 116 (2005) 347-358
7. Flecknell P.A. Refinement of animal use--assessment and alleviation of pain and distress. Lab Anim 28 3 (1994) 222-231
8. Flecknell P.A., Roughan J.V., and Stewart R. Use of oral buprenorphine ('buprenorphine jello') for postoperative analgesia in rats-a clinical trial. Lab Anim 33 2 (1999) 169-174
9. Goodwin J., and Bajwa Z. Evaluating the Patient with Chronic Pain. In: Warfield C., and Bajwa Z. (Eds). Principles and Practice of Pain Medicine (2004), McGraw-Hill, New York 61-68
10. Gourlay G.K. Advances in opioid pharmacology. Support Care Cancer 13 3 (2005) 153-159
11. Hendershot L.C., and Forsaith J. Antagonism of the frequency of phenylquinone-induced writhing in the mouse by weak analgesics and nonanalgesics. J Pharmacol Exp Ther 125 3 (1959) 237-240
12. Hill R. NK1 (substance P) receptor antagonists-why are they not analgesic in humans?. Trends Pharmacol Sci 21 7 (2000) 244-246
13. Hitzemann R., Dains K., Bier-Langing C.M., and Zahniser N.R. On the selection of mice for haloperidol response and non-response. Psychopharmacology (Berl) 103 2 (1991) 244-250
14. Hunskaar S., Fasmer O.B., and Hole K. Formalin test in mice. a useful technique for evaluating mild analgesics. J. Neurosci Met 14 (1985) 69-76
15. Jones C.K., Peters S.C., and Shannon H.E. Efficacy of duloxetine, a potent and balanced serotonergic and noradrenergic reuptake inhibitor, in inflammatory and acute pain models in rodents. J Pharmacol Exp Ther 312 (2005) 726-732
16. Kelley A.E., Bakshi V.P., Fleming S., and Holahan M.R. A pharmacological analysis of the substrates underlying conditioned feeding induced by repeated opioid stimulation of the nucleus accumbens. Neuropsychopharmacology 23 4 (2000) 455-467
17. Laird J.M.A., Martinez-Caro L., Garcia-Nicas E., and Cervero F. A new model of visceral pain and referred hyperalgesia in the mouse. Pain 92 (2001) 335-342
18. Lamonte N., Echo J.A., Ackerman T.F., Christian G., and Bodnar R.J. Analysis of opioid receptor subtype antagonist effects upon mu opioid agonist-induced feeding elicited from the ventral tegmental area of rats. Brain Res 929 1 (2002) 96-100
19. Le Bars D., Gozariu M., and Cadden S.W. Animal models of nociception. Pharmacol Rev 53 4 (2001) 597-652
20. Luger N.M., Sabino M.A.C., Schwei M.J., Mach D.B., Pomonis J.D., Keyser C.P., Rathbun M., Clohisy D.R., Honore P., Yaksh T.L., and Mantyh P.W. Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs. inflammatory pain. Pain 99 (2002) 397-406
21. Malick A., Jakubowski M., Elmquist J.K., Saper C.B., and Burstein R. A neurohistochemical blueprint for pain-induced loss of appetite. PNAS 98 17 (2001) 9930-9935
22. Martin T.J., Buechler N.L., Kahn W., Crews J.C., and Eisenach J.C. Effects of laparotomy on spontaneous exploratory activity and conditioned operant responding in the rat. a model for postoperative pain. Anesthesiology 101 1 (2004) 191-203
23. Melzack R. The McGill Pain Questionnaire. major properties and scoring methods. Pain 1 3 (1975) 277-299
24. Mogil J.S., and Crager S.E. What should we be measuring in behavioral studies of chronic pain in animals?. Pain 112 1-2 (2004) 12-15
25. NRC (National Research Council). Guide for the Care and Use of Laboratory Animals (1996), National Academy Press, Washington, DC 56-66
26. Ossipov M.H., Lai J., King T., Vanderah T.W., Malan T.P., Hruby Jr. V.J., and Porreca F. Antinociceptive and nociceptive actions of opioids. J Neurobiol 61 1 (2004) 126-148
27. Pearl J., Aceto M.D., and Harris L.S. Prevention of writhing and other effects of narcotics and narcotic antagonists in mice. J Pharmacol Exp Ther 160 1 (1968) 217-230
28. Reichert J.A., Daughters R.S., Rivard R., and Simone D.A. Peripheral and preemptive opioid antinociception in a mouse visceral pain model. Pain 89 2-3 (2001) 221-227
29. Roughan J.V., and Flecknell P.A. Buprenorphine. a reappraisal of its antinociceptive effects and therapeutic use in alleviating post-operative pain in animals. Lab Anim 36 3 (2002) 322-343
30. Roughan J.V., and PA F. Pain assessment and control in laboratory animals. Lab Anim 37 2 (2003) 172
31. Rowland N.E., Morien A., and Li B.H. The physiology and brain mechanisms of feeding. Nutrition 12 9 (1996) 626-639
32. Seguin L., Le Marouille-Girardon S., and Millan M.J. Antinociceptive profiles of non-peptidergic neurokinin1 and neurokinin2 receptor antagonists. a comparison to other classes of antinociceptive agent. Pain 61 2 (1995) 325-343
33. Silva R.M., Hadjimarkou M.M., Rossi G.C., Pasternak G.W., and Bodnar R.J. Beta-endorphin-induced feeding. pharmacological characterization using selective opioid antagonists and antisense probes in rats. J Pharmacol Exp Ther 297 2 (2001) 590-596
34. Stasiak K.L., Maul D., French E., Hellyer P.W., and WandeWoude S. Species-specific assessment of pain in laboratory animals. Contemp Top Lab Anim Sci 42 4 (2003) 13-20
35. Wells J.L., Bartlett J.L., Ananthan S., and Bilsky E.J. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence. J Pharmacol Exp Ther 297 2 (2001) 597-605
36. White S.M., Kucharik R.F., and Moyer J.A. Effects of serotonergic agents on isolation-induced aggression. Pharmacol Biochem Beh 39 (1991) 729-736
37. Yeomans D.C., and Proudfit H.K. Characterization of the foot withdrawal response to noxious radiant heat in the rat. Pain 59 1 (1994) 85-94